IDEXX > About IDEXX > Investor Relations > Financial Highlights
 

Financial Highlights

Most Recent Quarterly Results

Years ended December 31, 2005   2006   2007

dollars and shares in thousands, except per share data

 
Total revenue

638,095

  739,117

  922,555

Income from operations

115,331

127,933

136,183

Net income

78,254

93,678

94,014

Earnings per share: diluted

1.15

1.42

1.46

Weighted average shares outstanding: diluted

68,109

65,907

64,455

Net cash provided by operating activities

116,552

109,826

135,124

Cash and investments

132,731

96,666

60,360

Total assets

490,676

559,560

702,179

Debt

551

7,125

78,683

Total liabilities

121,366

149,699

263,856

Stockholders' equity

369,010

409,861

438,323

Historical share and per share data has been retroactively restated to reflect the additional shares of common stock that were distributed on November 26, 2007 as a result of the two-for-one split of our outstanding common stock.

Postings are made at such times as the company determines, at its discretion. Readers should not assume that the information contained on this site has been updated or otherwise contains current information. The company does not review past postings to determine whether they remain accurate, and information contained in such postings may have been superseded.

 
© 2008 IDEXX Laboratories, Inc.
All rights reserved.